HealthPharma & Biotech
viewValeritas Holdings Inc.

Shares of Valeritas Holdings jump after data-release underscores performance of flagship V-Go device

The New Jersey company says the data show the V-Go therapy resulted in better glycemic control and was well tolerated by patients

The commercial-stage company focuses on development and commercialization of medical technologies to treat patients with Type 2 diabetes in the US

Shares of Valeritas Holdings Inc (NASDAQ:VLRX) jumped Wednesday after releasing more data underscoring the quality and performance of its flagship V-Go Wearable Insulin Delivery device.

Valeritas’ stock recently traded up 6.6% to $4.02 a share on heavier-than-average volume. In pre-market trading, shares rose as high as 31%. 

The Bridgewater, New Jersey, medical-tech company said the data demonstrate that the V-Go therapy resulted in better glycemic control and improved attainment of quality performance measures, and was well tolerated by patients.

READ: Orgenesis showcases publication of diabetes study in Stem Cell Research and Therapy Journal

The data were pulled from the VERDICT study -- a real-world retrospective analysis of electronic health records from a large specialized diabetes center -- and announced at the International Society for Pharmacoeconomics and Outcomes Research's annual meeting in New Orleans, according to a statement.

“The VERDICT study demonstrates that significantly more patients achieved better control and attained improved quality metrics," said CEO John Timberlake. “We will continue to partner with clinicians to improve patient outcomes and quality of care delivered using V-Go as a standard way to deliver basal-bolus insulin therapy.”

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Valeritas Holdings Inc.

Price: 1.37 USD

Market: NASDAQ
Market Cap: $9.81 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



IGas is a 'diverse business with lots of opportunities' says CEO Bowler

Onshore UK focused IGas’s (LON:IGAS) production currently is 850,000 barrels per year, but that is dwarfed by its shale acreage in the East Midlands. This compares favourably with major shale plays in the US, says Bowler, who believes the reserves are sufficient to provide all the UK’s gas...

43 minutes ago

2 min read